OPENLANE, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that OPENLANE, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $494.30M | Feb 18, 2026 |
| FY2025 | Sep 30, 2025 | $498.40M | Feb 18, 2026 |
| FY2025 | Jun 30, 2025 | $481.70M | Feb 18, 2026 |
| FY2025 | Mar 31, 2025 | $460.10M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $455.00M | Feb 18, 2026 |
| FY2025 | Sep 30, 2024 | $459.80M | Feb 18, 2026 |
| FY2025 | Jun 30, 2024 | $443.80M | Feb 18, 2026 |
| FY2025 | Mar 31, 2024 | $429.90M | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $406.10M | Feb 20, 2025 |
| FY2024 | Sep 30, 2023 | $427.90M | Feb 20, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $177.70M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $109.90M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | ($154.10M) | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $241.20M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $66.50M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $500.0K | Mar 9, 2023 |
| FY2021 | Dec 31, 2019 | $188.50M | Feb 23, 2022 |
| FY2018 | Dec 31, 2018 | $67.30M | Feb 21, 2019 |
| FY2018 | Sep 30, 2018 | $77.50M | Feb 21, 2019 |
| FY2018 | Jun 30, 2018 | $93.20M | Feb 21, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $42.50M | Feb 18, 2026 |
| FY2025 | Sep 30, 2025 | $55.00M | Feb 18, 2026 |
| FY2025 | Jun 30, 2025 | $47.40M | Feb 18, 2026 |
| FY2025 | Mar 31, 2025 | $51.70M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $79.00M | Feb 18, 2026 |
| FY2025 | Sep 30, 2024 | $42.50M | Feb 18, 2026 |
| FY2025 | Jun 30, 2024 | $23.90M | Feb 18, 2026 |
| FY2025 | Mar 31, 2024 | $36.80M | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $23.40M | Feb 20, 2025 |
| FY2024 | Sep 30, 2023 | $32.30M | Feb 20, 2025 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $112.80M | Feb 18, 2026 |
| FY2025 | Sep 30, 2025 | $110.90M | Feb 18, 2026 |
| FY2025 | Jun 30, 2025 | $114.30M | Feb 18, 2026 |
| FY2025 | Mar 31, 2025 | $107.20M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $99.70M | Feb 18, 2026 |
| FY2025 | Sep 30, 2024 | $97.70M | Feb 18, 2026 |
| FY2025 | Jun 30, 2024 | $104.70M | Feb 18, 2026 |
| FY2025 | Mar 31, 2024 | $106.50M | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $101.40M | Feb 20, 2025 |
| FY2024 | Sep 30, 2023 | $105.40M | Feb 20, 2025 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $749.80M | Feb 21, 2019 |
| FY2018 | Dec 31, 2017 | $588.80M | Feb 21, 2019 |
| FY2018 | Dec 31, 2016 | $378.00M | Feb 21, 2019 |
| FY2017 | Dec 31, 2015 | $482.10M | Feb 21, 2018 |
| FY2016 | Dec 31, 2014 | $431.30M | Feb 24, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.72B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $4.62B | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $4.73B | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $5.12B | Feb 20, 2025 |
| FY2022 | Dec 31, 2021 | $7.45B | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $6.80B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $6.58B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $7.21B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $6.98B | Feb 21, 2019 |
| FY2018 | Dec 31, 2016 | $6.56B | Feb 21, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.24B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $1.34B | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $1.33B | Feb 18, 2026 |
| FY2025 | Dec 31, 2022 | $1.52B | Feb 18, 2026 |
| FY2024 | Dec 31, 2021 | $1.51B | Feb 20, 2025 |
| FY2023 | Dec 31, 2020 | $1.62B | Feb 21, 2024 |
| FY2022 | Dec 31, 2019 | $1.65B | Mar 9, 2023 |
| FY2021 | Dec 31, 2018 | $1.46B | Feb 23, 2022 |
| FY2020 | Dec 31, 2017 | $1.48B | Feb 18, 2021 |
| FY2019 | Dec 31, 2016 | $1.40B | Feb 19, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.24B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $1.22B | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $1.27B | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $1.46B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $1.60B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $1.16B | Mar 9, 2023 |
| FY2021 | Dec 31, 2019 | $1.82B | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $1.68B | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $1.65B | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $2.06B | Feb 21, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $586.70M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $689.80M | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $624.40M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $822.90M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $625.70M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $600.70M | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $651.00M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $392.30M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $257.00M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $74.10M | Feb 21, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $141.50M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $143.00M | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $93.50M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $225.70M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $177.60M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $752.10M | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $507.60M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $277.10M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $317.20M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $201.80M | Feb 21, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $550.00M | Feb 18, 2026 |
| FY2024 | Dec 31, 2024 | $230.70M | Feb 20, 2025 |
| FY2023 | Dec 31, 2023 | $364.60M | Feb 21, 2024 |
| FY2022 | Dec 31, 2022 | $498.70M | Mar 9, 2023 |
| FY2021 | Dec 31, 2021 | $1.89B | Feb 23, 2022 |
| FY2020 | Dec 31, 2020 | $1.90B | Feb 18, 2021 |
| FY2019 | Dec 31, 2019 | $1.92B | Feb 19, 2020 |
| FY2018 | Dec 31, 2018 | $2.69B | Feb 21, 2019 |
| FY2017 | Dec 31, 2017 | $2.70B | Feb 21, 2018 |
| FY2016 | Dec 31, 2016 | $2.50B | Feb 24, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 9, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Feb 23, 2022 |
| FY2018 | Dec 31, 2018 | 0 | Feb 21, 2019 |
| FY2018 | Sep 30, 2018 | 0 | Feb 21, 2019 |
| FY2018 | Jun 30, 2018 | 0 | Feb 21, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 9, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Feb 23, 2022 |
| FY2018 | Dec 31, 2018 | 0 | Feb 21, 2019 |
| FY2018 | Sep 30, 2018 | 0 | Feb 21, 2019 |
| FY2018 | Jun 30, 2018 | 0 | Feb 21, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 106.18M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | 106.85M | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | 108.04M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | 108.91M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | 121.16M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | 129.70M | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | 128.83M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | 132.89M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | 134.32M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | 136.64M | Feb 21, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $0 | Mar 9, 2023 |
| FY2022 | Dec 31, 2021 | $0 | Mar 9, 2023 |
| FY2022 | Dec 31, 2020 | $49.00M | Mar 9, 2023 |